AMKR Q2 2026 Earnings: Best Proven Results Boost Shares
AMKR Q2 2026 earnings show a 42.6% EPS beat, driving share prices up 5.9%.
Is Enfusion Stock Acquisition the Worst Move for Investors?
Enfusion stock acquisition news highlights the recent exit from NYSE after Clearwater’s takeover.
IM Cannabis Acquisition News: Worst Tactical Drone Move
IM Cannabis acquisition news reveals a major shift into tactical drones amid share price plunge. Discover the implications of this move.
Spinny IPO News: Smart Plans for Rs 3,000 Crore Launch
Spinny IPO news reveals plans for a Rs 3,000 crore launch, backed by Sachin Tendulkar, indicating strong market confidence.
Gujarat Themis Biosyn revenue: Proven growth with 17% rise
Gujarat Themis Biosyn revenue sees a 17% increase, reaching Rs 44.23 cr in Q4, showcasing strong financial performance.
Ola Electric COO resignation: A Smart Move for Growth
Ola Electric COO resignation marks a significant shift in leadership dynamics.